153 related articles for article (PubMed ID: 21943176)
1. A MCP1 fusokine with CCR2-specific tumoricidal activity.
Rafei M; Deng J; Boivin MN; Williams P; Matulis SM; Yuan S; Birman E; Forner K; Yuan L; Castellino C; Boise LH; MacDonald TJ; Galipeau J
Mol Cancer; 2011 Sep; 10():121. PubMed ID: 21943176
[TBL] [Abstract][Full Text] [Related]
2. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.
Rafei M; Berchiche YA; Birman E; Boivin MN; Young YK; Wu JH; Heveker N; Galipeau J
J Immunol; 2009 Aug; 183(3):1759-66. PubMed ID: 19592643
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine.
Rafei M; Campeau PM; Wu JH; Birman E; Forner K; Boivin MN; Galipeau J
J Immunol; 2009 Mar; 182(5):2620-7. PubMed ID: 19234156
[TBL] [Abstract][Full Text] [Related]
4. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
[TBL] [Abstract][Full Text] [Related]
6. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
[TBL] [Abstract][Full Text] [Related]
7. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
8. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
[TBL] [Abstract][Full Text] [Related]
9. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
Berencsi K; Rani P; Zhang T; Gross L; Mastrangelo M; Meropol NJ; Herlyn D; Somasundaram R
J Transl Med; 2011 Mar; 9():33. PubMed ID: 21450101
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery
Guo L; Zhang Y; Wei R; Zhang X; Wang C; Feng M
Theranostics; 2020; 10(15):6581-6598. PubMed ID: 32550891
[No Abstract] [Full Text] [Related]
11. Activation of SIRT1 promotes cartilage differentiation and reduces apoptosis of nucleus pulposus mesenchymal stem cells via the MCP1/CCR2 axis in subjects with intervertebral disc degeneration.
Ou X; Ying J; Bai X; Wang C; Ruan D
Int J Mol Med; 2020 Sep; 46(3):1074-1084. PubMed ID: 32705163
[TBL] [Abstract][Full Text] [Related]
12. A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.
Kalderén C; Forsgren M; Karlström U; Stefansson K; Svensson R; Berglund MM; Palm G; Selander M; Sundbom M; Nilsson J; Sjögren A; Zachrisson K; Gelius SS
Biochem Pharmacol; 2012 Mar; 83(5):644-52. PubMed ID: 22177985
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
14. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
15. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
16. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
17. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma.
Shono K; Yamaguchi I; Mizobuchi Y; Kagusa H; Sumi A; Fujihara T; Nakajima K; Kitazato KT; Matsuzaki K; Saya H; Takagi Y
Sci Rep; 2020 Sep; 10(1):15286. PubMed ID: 32943658
[TBL] [Abstract][Full Text] [Related]
19. The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency.
Yao Y; Tsirka SE
J Biol Chem; 2010 Oct; 285(41):31509-16. PubMed ID: 20682771
[TBL] [Abstract][Full Text] [Related]
20. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
Zhang J; Sarkar S; Cua R; Zhou Y; Hader W; Yong VW
Carcinogenesis; 2012 Feb; 33(2):312-9. PubMed ID: 22159219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
